A detailed history of Resolute Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Resolute Financial, LLC holds 5,195 shares of MRK stock, worth $500,330. This represents 0.49% of its overall portfolio holdings.

Number of Shares
5,195
Previous 4,929 5.4%
Holding current value
$500,330
Previous $425,000 35.53%
% of portfolio
0.49%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $23,259 - $29,821
266 Added 5.4%
5,195 $576,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $42,180 - $47,385
-499 Reduced 9.19%
4,929 $425,000
Q1 2022

Apr 15, 2022

BUY
$73.51 - $82.4 $13,084 - $14,667
178 Added 3.39%
5,428 $445,000
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $379,470 - $475,335
5,250 New
5,250 $402,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Resolute Financial, LLC Portfolio

Follow Resolute Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Financial, LLC with notifications on news.